Shorten your drug-to-market timeline or gain approval for expanded use of existing pharmaceuticals with help from TriMetis Life Sciences.
Our in-house regulatory experts can advise you as to the appropriate tests, models and protocols for your product — and conduct the bio/pharmaceutical in vivo toxicology testing required to meet FDA guidelines at our state-of-the-art 26,000-square-foot facility in Memphis, Tennessee.
Customized Strategies and Approaches
If you choose to have your own employees conduct the testing, we will work with you to provide access to all necessary facilities, support services and training/certification expertise needed to support your team.
Increasingly, the US Food and Drug Administration is requiring toxicological profiles of new or expanded use drug candidates that may pose a significant human health risk via environmental exposure. When your company is ready to bring a drug to market, or apply for expanded use of an existing pharmaceutical, we can conduct any or all of the following tests to meet FDA requirements.
ADME/PK (absorption, distribution, metabolism and excretion/pharmacokinetics)